Hallucinations

17 registered clinical trials studyying Hallucinations — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	HD-tDCS for Hallucinations NCT06208176	Hôpital le Vinatier	N/A
Unknown	Impact of Closely Grouped, Iterative Exposures to Suxamethonium During ECT on the Sensitization to NMBA and th NCT05210062	Assistance Publique - Hôpitaux de Paris	—
Unknown	Sound and Vision: A Collaboration Between Service-users, Artists and the Public to Explore the Lived Experienc NCT04399096	University of Cambridge	—
Unknown	ReMindCare App for Patients From First Episode of Psychosis Unit. NCT03807388	Instituto de Investigacion Sanitaria INCLIVA	N/A
Completed	Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD) NCT05240339	University of Rochester	—
Completed	Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis NCT02974400	University of Bern	N/A
Unknown	Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia NCT04352569	Centre hospitalier de Ville-Evrard, France	N/A
Completed	Cognitive Behaviour Therapy for Voices and Dissociation NCT04990414	Greater Manchester Mental Health NHS Foundation Trust	Phase 2
Unknown	Understanding Hallucinations (Part II) NCT02460965	Iris Sommer	—
Unknown	Understanding Hallucinations (Part I) NCT01907568	UMC Utrecht	—
Completed	Multimodal MRI-guided rTMS to Treat Refractory Hallucinations NCT01373866	University Hospital, Lille	N/A
Completed	Pain Medicine for Wound Care Procedures NCT00701909	University of California, San Francisco	Phase 3
Completed	Transcranial Magnetic Stimulation for "Voices" NCT00308997	Yale University	Phase 2
Completed	Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magn NCT00288340	Vanderbilt University	N/A
Completed	Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophreni NCT00328952	Seoul National University Hospital	—
Completed	Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug NCT00087542	ACADIA Pharmaceuticals Inc.	Phase 2
Completed	Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory Hallucinations NCT00042159	Yale University	N/A